Zobrazeno 1 - 10
of 1 011
pro vyhledávání: '"Pasqui F"'
Autor:
Pignot, G., Galiano, M., Hajage, D., Rouprêt, M., Pasqui, F., Chartier-Kastler, E., Bitker, M.-O., Richard, F.
Publikováno v:
In Progres en Urologie 2009 19(2):94-100
Autor:
Mazzo F; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Butnaru I; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Grubisha O; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Ficulle E; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Sanger H; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Fitzgerald G; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Pan F; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Pasqui F; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Murray T; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Monn J; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Li X; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Hutton M; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Bose S; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Schiavo G; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.)., Sher E; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F., Fe.P., J.M., X.L., M.H.); and Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom (G.S.) sher_emanuele@lilly.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 Nov; Vol. 383 (2), pp. 117-128. Date of Electronic Publication: 2022 Sep 18.
Autor:
Villanova, N.1, Pasqui, F.1, Burzacchini, S.1, Forlani, G.1, Manini, R.1, Suppini, A.1, Melchionda, N.1, Marchesini, G.1 giulio.marchesini@unibo.it
Publikováno v:
International Journal of Obesity. Apr2006, Vol. 30 Issue 4, p697-703. 7p. 2 Charts, 2 Graphs.
Autor:
Aljaaly, Elham A.1,2 (AUTHOR) ealjaaly@kau.edu.sa, Khatib, Mai A.1,3,4 (AUTHOR) mkhatib@kau.edu.sa
Publikováno v:
Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 15, p1630. 13p.
Autor:
Pantoja-Arévalo, Lisset1 (AUTHOR) l.pantoja@upm.es, Gesteiro, Eva1 (AUTHOR), Pérez-Ruiz, Margarita1 (AUTHOR), López-Seoane, Jaime1 (AUTHOR), Wusterhausen, Patricia2 (AUTHOR), Matthias, Torsten2 (AUTHOR), Urrialde, Rafael3,4,5 (AUTHOR), González-Gross, Marcela1,6 (AUTHOR)
Publikováno v:
Trials. 7/20/2024, Vol. 25 Issue 1, p1-18. 18p.
Autor:
Luvero, Daniela1 (AUTHOR), Silvagni, Adele1 (AUTHOR) adele.silvagni@unicampus.it, Angioli, Anna Maria2 (AUTHOR), Filippini, Maurizio3 (AUTHOR), Plotti, Francesco1 (AUTHOR), Montera, Roberto1 (AUTHOR), De Cicco Nardone, Carlo1 (AUTHOR), Notaro, Erika1 (AUTHOR), Branda, Francesco4 (AUTHOR), Angioli, Roberto1 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 12, p3550. 14p.
Autor:
Trimigno A; Chemometrics and Analytical Technology Section, Department of Food Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Khakimov B; Chemometrics and Analytical Technology Section, Department of Food Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Savorani F; Department of Applied Science and Technology (DISAT), Polytechnic University of Turin, 10129 Torino, Italy., Tenori L; Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy., Hendrixson V; Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania., Čivilis A; Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania., Glibetic M; Centre of Research Excellence in Nutrition and Metabolism Research, Institute for Medical Research, University of Belgrade, Tadeusa Koscuska 1, P.O. Box 102, 11000 Belgrade, Serbia., Gurinovic M; Centre of Research Excellence in Nutrition and Metabolism Research, Institute for Medical Research, University of Belgrade, Tadeusa Koscuska 1, P.O. Box 102, 11000 Belgrade, Serbia., Pentikäinen S; VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 VTT, Finland., Sallinen J; VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 VTT, Finland., Garduno Diaz S; School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT, UK., Pasqui F; Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy., Khokhar S; Food4Nutrition Ltd, LS16 6AA Leeds, UK., Luchinat C; CERM, Center of Magnetic Resonance, University of Florence, Via Luigi Sacconi 6, 50019, Sesto Fiorentino, Florence, Italy., Bordoni A; Department of Agricultural and Food Sciences, Alma Mater Studiorum University of Bologna Piazza G. Goidanich, 60 - 47521, Cesena, Italy., Capozzi F; Department of Agricultural and Food Sciences, Alma Mater Studiorum University of Bologna Piazza G. Goidanich, 60 - 47521, Cesena, Italy., Balling Engelsen S; Chemometrics and Analytical Technology Section, Department of Food Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark.
Publikováno v:
Molecular nutrition & food research [Mol Nutr Food Res] 2019 Jan; Vol. 63 (1), pp. e1800216. Date of Electronic Publication: 2018 Jun 25.
Autor:
Broad LM; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Sanger HE; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Mogg AJ; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Colvin EM; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Zwart R; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Evans DA; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Pasqui F; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Sher E; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Wishart GN; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Barth VN; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Felder CC; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Goldsmith PJ; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2019 Jan; Vol. 176 (1), pp. 110-126. Date of Electronic Publication: 2018 Nov 16.
Per encefalopatia epatica si intende la comparsa di alterazioni neuropsichiche conseguenti all'insufficienza epatica acuta e cronic, allo shunt porto-sistemico, o ad entrambe. vengono identificati tre tipi di encefalopatia (A,B e C) rispettivamente a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4570ff3e789604d0841dc83b8c1e1aed
http://hdl.handle.net/11585/57787
http://hdl.handle.net/11585/57787
L'ecosistema intestinale costituisce uno degli ecosistemi più complessi dell'uomo sia per l'elevata concentrazione microbica si a per la complessità della sua composizione. Le specie batteriche più rappresentative del colon sono quelle appartenent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8b90c6de8a879c17661285c309229366
http://hdl.handle.net/11585/57732
http://hdl.handle.net/11585/57732